These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2930201)

  • 1. [Bestatin treatment of patients with myelodysplastic syndromes].
    Uzuka Y; Saito Y
    Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 1):365-70. PubMed ID: 2930201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bestatin treatment of myelodysplastic syndromes (MDS) and the effects of bestatin on hematopoiesis in MDS.
    Uzuka Y; Saito Y
    Acta Oncol; 1990; 29(6):803-7. PubMed ID: 2223153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential responses of myeloid progenitor cells from patients with myeloid leukemia and myelodysplasia to the costimulating effects of steel factor in vitro.
    Maze R; Horie M; Hendrie P; Vadhan-Raj S; Tricot G; Gordon M; Nemunaitis J; Ashman LK; Broxmeyer HE
    Exp Hematol; 1993 Apr; 21(4):545-51. PubMed ID: 7681784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial review of immunotherapeutic pharmacology in stem cell transplantation.
    Bierman PJ; Abe F; Buyukberber S; Ino K; Talmadge JE
    In Vivo; 2000; 14(1):221-36. PubMed ID: 10757081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged response to cyclosporin-A in hypoplastic refractory anemia and correlation with in vitro studies.
    Catalano L; Selleri C; Califano C; Luciano L; Volpicelli M; Rocco S; Varriale G; Ricci P; Rotoli B
    Haematologica; 2000 Feb; 85(2):133-8. PubMed ID: 10681719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of in vivo treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on proliferation kinetics of bone marrow and blood myeloid progenitor cells in patients with sarcoma.
    Broxmeyer HE; Benninger L; Cooper S; Hague N; Benjamin RS; Vadhan-Raj S
    Exp Hematol; 1995 Apr; 23(4):335-40. PubMed ID: 7895781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth characteristics of circulating hematopoietic progenitors in terminal renal failure.
    Glaser M
    Med Sci Monit; 2006 Mar; 12(3):CR113-7. PubMed ID: 16501421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A new antitumor drug with immunomodulating activity, ubenimex (bestatin)].
    Tsukagoshi S
    Gan To Kagaku Ryoho; 1987 Jul; 14(7):2385-91. PubMed ID: 3496857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells.
    Broxmeyer HE; Lu L; Platzer E; Feit C; Juliano L; Rubin BY
    J Immunol; 1983 Sep; 131(3):1300-5. PubMed ID: 6193183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cyclosporine on hematopoietic and immune functions in patients with hypoplastic myelodysplasia: in vitro and in vivo studies.
    Selleri C; Maciejewski JP; Catalano L; Ricci P; Andretta C; Luciano L; Rotoli B
    Cancer; 2002 Nov; 95(9):1911-22. PubMed ID: 12404285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of treatment with 13-cis-retinoic acid and ara-C on the hematopoietic stem cells of patients with myelodysplastic syndromes].
    García Marco J; Miguel Sosa A; García Conde J; Miguel García A; Arbona C; Escrig V; Benet I; Navarro I; Ruiz A; Carbonell F
    Sangre (Barc); 1994 Aug; 39(4):241-4. PubMed ID: 7985051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic effects of purified recombinant human and murine B cell growth factor-1/IL-4 on colony formation in vitro by hematopoietic progenitor cells. Multiple actions.
    Broxmeyer HE; Lu L; Cooper S; Tushinski R; Mochizuki D; Rubin BY; Gillis S; Williams DE
    J Immunol; 1988 Dec; 141(11):3852-62. PubMed ID: 3053902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The implications of the biological indices examination of bone marrow cells in myelodysplastic syndromes].
    Zhang F; Hao Y; Pang W
    Zhonghua Xue Ye Xue Za Zhi; 2001 Oct; 22(10):528-32. PubMed ID: 11769678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro response of normal and aplastic anemia bone marrow to mast cell growth factor and in combination with granulocyte-macrophage colony-stimulating factor and interleukin-3.
    Gibson FM; Scopes J; Daly S; Ball SE; Gordon-Smith EC
    Exp Hematol; 1994 Mar; 22(3):302-12. PubMed ID: 8112428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of adult human marrow hematopoietic progenitors highly enriched by two-color cell sorting with My10 and major histocompatibility class II monoclonal antibodies.
    Lu L; Walker D; Broxmeyer HE; Hoffman R; Hu W; Walker E
    J Immunol; 1987 Sep; 139(6):1823-9. PubMed ID: 3114377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thy-1 antigen expression by murine high-proliferative capacity hematopoietic progenitor cells. I. Relation between sensitivity to depletion by Thy-1 antibody and stem cell generation potential.
    Boswell HS; Wade PM; Quesenberry PJ
    J Immunol; 1984 Dec; 133(6):2940-9. PubMed ID: 6149245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of 1,25-dihydroxyvitamin D3 and 13-cis-retinoic acid on in vitro hematopoiesis in the myelodysplastic syndromes.
    Nagler A; Rikilis I; Tatarsky I; Fabian I
    J Lab Clin Med; 1987 Aug; 110(2):237-44. PubMed ID: 3474327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of stem cell factor on myelopoiesis potential in human Dexter-type culture systems.
    Liesveld JL; Broudy VC; Harbol AW; Abboud CN
    Exp Hematol; 1995 Mar; 23(3):202-9. PubMed ID: 7533098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cells.
    Miller CL; Rebel VI; Lemieux ME; Helgason CD; Lansdorp PM; Eaves CJ
    Exp Hematol; 1996 Feb; 24(2):185-94. PubMed ID: 8641340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.